Navigation Links
NAMS journal Menopause reflects on the WHI 10 years later
Date:5/29/2012

CLEVELAND, OH (May 29, 2012) A great deal has been learned in the decade since the first results from the Women's Health Initiative (WHI) were published on July 9, 2002. The WHI was the largest and longest trial of postmenopausal women using hormone therapy (HT). The 27,000 women were prescribed estrogen-alone therapy, estrogen-progestogen therapy, or a placebo for 5 to 7 years, respectively.

Researchers expected to find that hormones prevented chronic conditions of aging in women, including heart disease. Instead, they found that hormones produced a mix of risks and benefits. The subsequent data from the WHI suggest that the risks of HT vary with a woman's age (safer if started soon after menopause).

To commemorate the 10th anniversary of this landmark trial and its voluminous reporting, the June 2012 issue of Menopause will publish an editorial by JoAnn E. Manson, MD, DrPH, NCMP (NAMS President) and Lubna Pal, MBBS, MRCOG, MSc, NCMP, entitled "The Women's Health Initiative: An Unforgettable Decade," along with several other timely articles:

  • "Evolution of Postmenopausal Hormone Therapy Between 2002 and 2009" by Bruce Ettinger, MD, Sharon M. Wang, PharmD, MS, R. Scott Leslie, MPH, et al.
  • "A Decade of Postmenopausal Hormone Therapy Prescribing in the United States: Long-Term Effects of the WHI" by Amy Steinkellner, PharmD, Shannon Denison, MA, Sandra Eldridge, PharmD, et al.
  • "Hormone Therapy Prescribing Trends in the Decade After the Women's Health Initiative: How Patients and Providers Have Found a Way to Sleep Better at Night" by Jennifer Corbelli, MD, Rachel Hess, MD, MS (editorial)

These articles will be available on Menopause online on May 31, 2012 at 4:00 PM EST.


'/>"/>

Contact: Carolyn Develen
carolyn@menopause.org
440-442-7657
The North American Menopause Society (NAMS)
Source:Eurekalert

Page: 1

Related medicine news :

1. Reactions to HIV drug have autoimmune cause, reports AIDS journal
2. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
3. Journals and pharma collaborate on new recommendations
4. Model for breast cancer rehab featured in supplement to ACS journal, Cancer
5. Springer launches 6 new medical review journals
6. Oxford University Press to publish open access title Journal of Radiation Research
7. Major cancer societies to support new Wiley Open Access Journal
8. C. Noel Bairey Merz to receive inaugural Journal of Womens Health Award at 20th Annual Congress on Womens Health
9. Journal Retracts Faulty Chronic Fatigue Study
10. Journal names discovery that HIV treatment can prevent spread breakthrough of the year
11. Journal of Clinical Virology assembles papers on HIV diagnostic testing algorithms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , ... July 31, 2015 , ... ... announced plans to release a newly redesigned website at Healthpointe.net. The new website ... user experience. , The redesign serves to provide smoother interactions between patients ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Women's ... Center for Natural Birth . The Karmanos Center for Natural Birth provides ... experience. With nurses and caregivers that are trained in holistic birth approaches, patients ...
(Date:7/31/2015)... ... July 31, 2015 , ... A ... natural, therapeutic-grade oils from ingredients sourced all over the world, then manufactured into ... effort, we have developed the highest-quality oils in the industry, which we are ...
(Date:7/31/2015)... ... July 31, 2015 , ... Super-Sod wants to participate in planning new home ... as the perfect fit for such a goal. Houzz is a social media ... is a dynamic site that spreads home and home garden design ideas when members ...
(Date:7/31/2015)... Orlando, FL (PRWEB) , ... July 31, 2015 , ... ... visiting the United States for temporary work, study or family visit for the past ... in their 80s and 90s are able to travel and spend time with their ...
Breaking Medicine News(10 mins):Health News:Healthpointe Announces Newly Redesigned Website 2Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3
... growing brain tumors must adjust to periods of low ... cells grow and proliferate. When levels are low, the ... Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer ... the switch responsible for this grow-or-go behavior. , Their ...
... that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala . , ... , , ... ... ...
... author, and lecturer Dr. William Sears and his product team have announced the launch of ... Expo West convention to be held in Anaheim, CA March 12-14 . The company,s ... ... ...
... ... and food security has wide-ranging benefits compared to its costs in the fight against ... Congressional hearing on global hunger. He cites findings from Nobel laureates and a Lancet ... ...
... ... ... 11, 2010 -- Qualifacts Systems Inc. , the largest Software as a Service ... and human services providers, has added New Directions Inc. to its client roster – ...
... ... President of International Orion Health – Charles Scatchard. Orion Health celebrates “phenomenal success” with ... , ... (PRWEB) March 12, 2010 -- To further the ongoing success with implementing Healthcare IT ...
Cached Medicine News:Health News:Researchers discover brain tumor's 'grow-or-go' switch 2Health News:Researchers discover brain tumor's 'grow-or-go' switch 3Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 2Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 3Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 4Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 5Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 2Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 3Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 2Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 3Health News:Qualifacts is Behavioral Health SaaS Provider of Choice in Connecticut 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 3Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 4Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 5
(Date:7/31/2015)... 2015  Semler Scientific, Inc. (Nasdaq: SMLR ), ... healthcare insurers and physician groups, today reported financial results ... "In the second quarter of 2015, Semler ... of 54%, quarter over quarter revenue growth of 8%, ... of FloChec® units of 18%," said Doug Murphy-Chutorian, M.D., ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Yujiro S. Hata to its board of ... business and corporate development is a tremendous asset to ... and chief executive officer of Xencor. "Xencor faces a ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... - the novel,selective relaxant binding agent (SRBA) being ... Akzo Nobel - demonstrated in,a Phase III pivotal ... as compared to neostigmine, without evidence,of post operative ... The results of this pivotal Aurora trial,were presented ...
... 11, 2007 (MARKET WIRE via COMTEX News,Network) ... target=,"_blank" href="http://www.myriad.com/">www.myriad.com ),announced today that it presented ... a "Randomized Withdrawal" clinical trial,design with a ... the Alzheimer's Association Prevention Conference held,June 9 ...
Cached Medicine Technology:Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5
PremierEdge™ Stab Knives - 45°....
PremierEdge Stab Knives - 15....
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... use of the Leica CM1900 as well ... the instrument of choice in many routine ... open top stainless steel cryochamber with separate ... ample space for convenient working and storage ...
Medicine Products: